PortfoliosLab logoPortfoliosLab logo
NUTX vs. ATAI
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

NUTX vs. ATAI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Nutex Health Inc (NUTX) and Atai Life Sciences N.V. (ATAI). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, NUTX achieves a -10.44% return, which is significantly lower than ATAI's 75.55% return.


NUTX

1D
-0.86%
1M
-24.98%
6M
-0.91%
YTD
-10.44%
1Y
75.51%
3Y*
34.96%
5Y*
10Y*
ALL TIME*
-42.12%

ATAI

1D
0.00%
1M
38.34%
6M
90.96%
YTD
75.55%
1Y
72.18%
3Y*
51.86%
5Y*
-14.26%
10Y*
ALL TIME*
-18.92%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$95.05M$137.83M$67.37M
$17.86M$21.25M$20.00M

NUTX vs. ATAI - Yearly Performance Comparison


2026 (YTD)2025202420232022
NUTX
Nutex Health Inc
-10.44%419.47%17.37%-90.53%-81.82%
ATAI
Atai Life Sciences N.V.
75.55%207.52%-5.67%-46.99%-50.00%

Correlation

The correlation between NUTX and ATAI is 0.15, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.15

Correlation (3Y)
Balances recent behavior with more history.

0.18

Correlation (All Time)
Calculated using the full available price history since Apr 4, 2022

0.18

Fundamentals

Market Cap

NUTX:

$1.01B

ATAI:

$2.66B

EPS

NUTX:

$20.14

ATAI:

-$2.50

PS Ratio

NUTX:

0.80

ATAI:

546.93

Total Revenue (TTM)

NUTX:

$879.95M

ATAI:

$3.49M

Gross Profit (TTM)

NUTX:

$417.67M

ATAI:

$3.49M

EBITDA (TTM)

NUTX:

$275.94M

ATAI:

-$663.38M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

NUTX vs. ATAI — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

NUTX
NUTX Risk / Return Rank: 7171
Overall Rank
NUTX Sharpe Ratio Rank: 7171
Sharpe Ratio Rank
NUTX Sortino Ratio Rank: 7373
Sortino Ratio Rank
NUTX Omega Ratio Rank: 7272
Omega Ratio Rank
NUTX Calmar Ratio Rank: 7272
Calmar Ratio Rank
NUTX Martin Ratio Rank: 6969
Martin Ratio Rank

ATAI
ATAI Risk / Return Rank: 7474
Overall Rank
ATAI Sharpe Ratio Rank: 7474
Sharpe Ratio Rank
ATAI Sortino Ratio Rank: 7979
Sortino Ratio Rank
ATAI Omega Ratio Rank: 7676
Omega Ratio Rank
ATAI Calmar Ratio Rank: 7474
Calmar Ratio Rank
ATAI Martin Ratio Rank: 6868
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

NUTX vs. ATAI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Nutex Health Inc (NUTX) and Atai Life Sciences N.V. (ATAI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


NUTXATAIDifference
Sharpe ratioReturn per unit of total volatility

-0.12

Sortino ratioReturn per unit of downside risk

-0.32

Omega ratioGain probability vs. loss probability

1.20

1.23

-0.03

Calmar ratioReturn relative to maximum drawdown

1.37

1.57

-0.20

Martin ratioReturn relative to average drawdown

2.68

2.43

+0.25

NUTX vs. ATAI - Sharpe Ratio Comparison

The current NUTX Sharpe Ratio is 0.81, which is comparable to the ATAI Sharpe Ratio of 0.94. The chart below compares the historical Sharpe Ratios of NUTX and ATAI, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

NUTX vs. ATAI - Drawdown Comparison

The maximum NUTX drawdown since its inception was -99.93%, which is greater than ATAI's maximum drawdown of -95.05%. Use the drawdown chart below to compare losses from any high point for NUTX and ATAI.


Loading charts...

Drawdown Indicators


NUTXATAIDifference

Max Drawdown

Largest peak-to-trough decline

-99.93%

-95.05%

-4.88%

Max Drawdown (1Y)

Largest decline over 1 year

-54.32%

-48.06%

-6.26%

Max Drawdown (3Y)

Largest decline over 3 years

-92.39%

-59.23%

-33.16%

Max Drawdown (5Y)

Largest decline over 5 years

-94.17%

Current Drawdown

Current decline from peak

-97.54%

-65.81%

-31.73%

Average Drawdown

Average peak-to-trough decline

-97.19%

-80.58%

-16.61%

Ulcer Index

Depth and duration of drawdowns from previous peaks

27.59%

30.99%

-3.40%

Volatility

NUTX vs. ATAI - Volatility Comparison

The current volatility for Nutex Health Inc (NUTX) is 15.79%, while Atai Life Sciences N.V. (ATAI) has a volatility of 33.68%. This indicates that NUTX experiences smaller price fluctuations and is considered to be less risky than ATAI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


NUTXATAIDifference

Volatility (1M)

Calculated over the trailing 1-month period

15.79%

33.68%

-17.89%

Volatility (6M)

Calculated over the trailing 6-month period

60.57%

61.09%

-0.52%

Volatility (1Y)

Calculated over the trailing 1-year period

91.11%

82.57%

+8.54%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

189.30%

85.28%

+104.02%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

189.30%

84.88%

+104.42%

Dividends

NUTX vs. ATAI - Dividend Comparison

Neither NUTX nor ATAI has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

NUTX vs. ATAI - Financials Comparison

This section allows you to compare key financial metrics between Nutex Health Inc and Atai Life Sciences N.V.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

Frequently Asked Questions


NUTX and ATAI have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ATAI has higher volatility (33.68%) compared to NUTX (15.79%). In terms of maximum drawdown, NUTX dropped -99.93% vs ATAI's -95.05%.

ATAI currently has the higher Sharpe Ratio (0.94 vs 0.81), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for NUTX and ATAI

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer